Abbott Laboratories (ABT)
Net profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 5,723,000 | 6,933,000 | 7,071,000 | 4,495,000 | 3,687,000 |
| Revenue | US$ in thousands | 39,431,000 | 43,093,000 | 42,541,000 | 34,070,000 | 31,164,000 |
| Net profit margin | 14.51% | 16.09% | 16.62% | 13.19% | 11.83% |
December 31, 2023 calculation
Net profit margin = Net income ÷ Revenue
= $5,723,000K ÷ $39,431,000K
= 14.51%
Net profit margin is a key financial ratio that reflects the percentage of net income Abbott Laboratories generates from its total revenue. Over the past five years, Abbott's net profit margin has shown some fluctuations. In 2019, the company had a net profit margin of 11.56%, which increased to 12.99% in 2020. The margin further improved to 16.42% in 2021 before slightly decreasing to 15.88% in 2022 and then to 14.27% in 2023.
Overall, Abbott Laboratories has maintained a relatively healthy net profit margin above 10% in the past five years, indicating the company's ability to effectively control costs and generate profits from its operations. The downward trend observed in the most recent years could be an area of concern, and further analysis may be required to understand the factors contributing to this decrease.
Peer comparison
Dec 31, 2023